Sandeep Gupta
CEO,
Leukogene Therapeutics Inc
United States
Dr. Sandeep Gupta joined Leukogene as CEO in November 2024. Dr. Gupta has a distinguished career spanning 25+ years in pharma/biotech as a senior executive and entrepreneur. He founded Asana BioSciences and was its CEO and President. Under his leadership, Asana advanced multiple oncology and immunology programs, including an ADC, from discovery stage into clinical development, demonstrated clinical PoC and raised private financing. He also successfully out-licensed multiple Asana assets. Before joining Leukogene, Dr. Gupta was the CEO of Kashiv BioSciences LLC, a fully integrated biopharmaceutical company developing and manufacturing biosimilars.
Previously, he was Senior Vice President of Discovery and Early Development at Endo Health Solutions, and Head of Discovery and Pharmacology at Forest Laboratories.
Dr. Gupta also held academic positions at the University of Pennsylvania and Boston University Schools of Medicine. Dr. Gupta is an inventor on >20 patents and has authored >50 scientific papers and book chapters. He is a member of ASCO and AACR and was a member of The CEO Roundtable on Cancer.
Suffix
PhD
Sessions
-
11-Feb-2025PlymouthLeukogene Therapeutics Inc.
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}